| GATA2 | GATA binding protein 2 | 10 | gGATa | plus | ||
| a = 28% | ||||||
| GATA3 | GATA binding protein 3 | 2 | gGATat | plus | ||
| a = 62% | ||||||
| KLF4 | Krueppel-like factor 4 | 1 | tGGGtGtata | minus | ||
| t = 7% | ||||||
| ZNF354C | Zinc finger protein 354C | 4 | ataCAC | plus | ||
| a = 44% | ||||||
| rs5756 | C | ARNT:AHR | aryl hydrocarbon receptor nuclear translocator aryl hydrocarbon receptor | 28 | gGCGTG | plus |
| (C/T) | G = 96% | |||||
| 3’UTR | BRCA1 | breast cancer 1, early onset | 22 | ccAccac | minus | |
| c = 51% | ||||||
| EN1 | Engrailed homeobox 1 | 5 | gcgtggtggcg | plus | ||
| g = 70% | ||||||
| HIF1α:ARNT | Hypoxia-inducible factor 1: Aryl hydrocarbon receptor nuclear translocator | 10 | gggCGTGg | plus | ||
| G = 100% | ||||||
| KLF4 | Krueppel-like factor 4 | 4 | cGGGcGtggt | plus | ||
| G = 98% | ||||||
| PAX2 | Paired box gene 2 | 9 | cacCacgc | minus | ||
| c = 55% | ||||||
| TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 8 | GCCaccacg | minus | ||
| c = 9% | ||||||
| TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 5 | GCCgggcgt | plus | ||
| g = 74% | ||||||
| ZNF354C | Zinc finger protein 354C | 37 | caCCAC | minus | ||
| C = 94% | ||||||
| T | NFIC | Nuclear factor 1 C-type | 18 | cgGGca | plus | |
| a = 48% | ||||||
| NFE2L1:MAFG | Nuclear factor erythroid 2-related factor 1 Transcription factor MafG | 20 | caTGcc | minus | ||
| T = 100% | ||||||
| TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 8 | GCCaccatg | minus | ||
| t = 7% | ||||||
| ZEB1 | Zinc finger E-box binding homeobox 1 | 22 | cACCat | minus | ||
| t = 34% | ||||||
| YY1 | YY1 transcription factor | 22 | aCCATg | minus | ||
| T = 100% |